YU48213B - Postupak za izradu derivata aril (ili heteroaril) piperazinilbutilazola - Google Patents
Postupak za izradu derivata aril (ili heteroaril) piperazinilbutilazolaInfo
- Publication number
- YU48213B YU48213B YU21592A YU21592A YU48213B YU 48213 B YU48213 B YU 48213B YU 21592 A YU21592 A YU 21592A YU 21592 A YU21592 A YU 21592A YU 48213 B YU48213 B YU 48213B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- radical
- denotes
- aryl
- optionally substituted
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Ovaj pronalazak se odnosi na postupak za izradu derivata aril (ili heteroaril) piperazinibutilazola koji odgovaraju opštoj formuli u kojoj Ar označava azotni ili drugi radikal odabran od različito supstituisanog 2-pirimidina, 2-N-metilimidazola i 3-(1,2-benzizotiazola) Z1 označava atom azota ili po izboru supstituisani ugljenikov atom koji može da bude označen sa: C-R1 Z2 označava atom azota ili po izboru supstituisani ugljenikov atom koji može da bude označen sa: C-R2 Z4 označava atom azota ili po izboru supstituisani ugljenikov atom koji može da bude označen sa: C-R4 i R1, R2, R3 i R4, koji su isti ili različiti i mogu takodje da obrazuju deo drugog prstena, aromatskog ili drugačijeg, označavaju atom vodonika, halogen, niži alkil radikal, nitro radikal, hidroksil radikal, alkoksi radikal, cijano radikal, kar-boksilni radikal, karboksamido radikal, alkilkarboksilatni radikal, aril ili supstituisani aril radikal, sulfonski radikal, sulfonamido radikal po izboru supstituisan na amino grupi ili amino ili amino supstituisani radikal, naznačen time, što jedinjenje opšte formule IX u kojoj Ar ima značenje navedene gore i X označava halogeni atom, reaguje sa jedinjenjem opšte formule III u kojoj Z1, Z2, Z4 i R3 imaju značenja navedena gore. - Prijava sadrži još 6 zavisnih zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9102735A FR2673628B1 (fr) | 1991-03-07 | 1991-03-07 | Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles. |
Publications (2)
Publication Number | Publication Date |
---|---|
YU21592A YU21592A (sh) | 1994-06-24 |
YU48213B true YU48213B (sh) | 1997-08-22 |
Family
ID=9410449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU21592A YU48213B (sh) | 1991-03-07 | 1992-03-02 | Postupak za izradu derivata aril (ili heteroaril) piperazinilbutilazola |
Country Status (17)
Country | Link |
---|---|
US (1) | US5227486A (sh) |
EP (1) | EP0502786B1 (sh) |
JP (1) | JP3084537B2 (sh) |
KR (1) | KR0124133B1 (sh) |
AT (1) | ATE137233T1 (sh) |
AU (1) | AU651177B2 (sh) |
CA (1) | CA2062468A1 (sh) |
DE (1) | DE69210076T2 (sh) |
DK (1) | DK0502786T3 (sh) |
ES (1) | ES2036145B1 (sh) |
FR (1) | FR2673628B1 (sh) |
GR (1) | GR3020341T3 (sh) |
HU (1) | HU219405B (sh) |
NO (1) | NO180376C (sh) |
RU (1) | RU2053230C1 (sh) |
YU (1) | YU48213B (sh) |
ZA (1) | ZA921682B (sh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2665161B1 (fr) * | 1990-07-26 | 1992-11-27 | Esteve Labor Dr | Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments. |
US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
US5646281A (en) * | 1990-12-28 | 1997-07-08 | Neurogen Corporation | Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands |
FR2701260B1 (fr) * | 1993-02-05 | 1995-05-05 | Esteve Labor Dr | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. |
FR2705098B1 (fr) * | 1993-05-10 | 1995-08-04 | Esteve Labor Dr | Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) . |
WO1995003298A1 (en) * | 1993-07-19 | 1995-02-02 | Fujisawa Pharmaceutical Co., Ltd. | BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST |
US5521313A (en) * | 1994-05-05 | 1996-05-28 | Bristol-Myers Squibb Company | Process for preparing certain azapirones |
FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
US6355659B1 (en) | 1994-07-29 | 2002-03-12 | Laboratorios Del Dr. Esteve, S.A. | 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same |
GB9500580D0 (en) * | 1995-01-12 | 1995-03-01 | Merck Sharp & Dohme | Therapeutic agents |
ES2099031B1 (es) * | 1995-05-31 | 1997-12-01 | Esteve Labor Dr | Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen. |
US6011052A (en) * | 1996-04-30 | 2000-01-04 | Warner-Lambert Company | Pyrazolone derivatives as MCP-1 antagonists |
FR2763950B1 (fr) * | 1997-06-02 | 2002-09-20 | Esteve Labor Dr | 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique |
US6166205A (en) * | 1998-09-02 | 2000-12-26 | Neurogen Corporation | 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands |
US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
AU8125501A (en) | 2000-08-14 | 2002-02-25 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
ATE324372T1 (de) | 2000-08-14 | 2006-05-15 | Ortho Mcneil Pharm Inc | Substituierte pyrazole |
WO2002014315A2 (en) | 2000-08-14 | 2002-02-21 | Ortho Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
AU2001288714A1 (en) | 2000-09-06 | 2002-03-22 | Ortho-Mcneil Pharmaceutical, Inc. | A method for treating allergies |
GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
CN1867336B (zh) | 2002-06-12 | 2010-05-12 | 凯莫森特里克斯股份有限公司 | 1-芳基-4-取代的哌嗪衍生物及其制药用途 |
US20050256130A1 (en) * | 2002-06-12 | 2005-11-17 | Chemocentryx, Inc. | Substituted piperazines |
US7589199B2 (en) * | 2002-06-12 | 2009-09-15 | Chemocentryx, Inc. | Substituted piperazines |
US7842693B2 (en) * | 2002-06-12 | 2010-11-30 | Chemocentryx, Inc. | Substituted piperazines |
CA2428237C (en) * | 2003-05-08 | 2010-07-20 | Delmar Chemicals Inc. | Process for the preparation of carbostyril derivatives |
EP1720545B1 (en) * | 2004-03-03 | 2014-10-29 | ChemoCentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
US7435831B2 (en) * | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
CA2575180A1 (en) | 2004-08-03 | 2006-02-16 | Wyeth | Indazoles useful in treating cardiovascular diseases |
JP2006169154A (ja) * | 2004-12-15 | 2006-06-29 | Sumitomo Chemical Co Ltd | 第四級アンモニウム塩の製造方法 |
EP2924032B1 (en) * | 2012-11-26 | 2019-03-06 | Shenyang Haiwang Biotechnology Co., Ltd | Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof |
CN105669665A (zh) * | 2016-03-15 | 2016-06-15 | 烟台贝森医药科技有限公司 | 哌罗匹隆的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1279645C (en) * | 1986-02-27 | 1991-01-29 | Ineke Van Wijngaarden | Aryl-substituted (n-piperidinyl)methyl- and (n-piperazinyl)methylazoles having antipsychotic properties |
FR2642759B1 (fr) * | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
US5077293A (en) * | 1990-06-29 | 1991-12-31 | Bristol-Myers Squibb Co. | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
-
1991
- 1991-03-07 FR FR9102735A patent/FR2673628B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-02 YU YU21592A patent/YU48213B/sh unknown
- 1992-03-04 AT AT92400565T patent/ATE137233T1/de not_active IP Right Cessation
- 1992-03-04 EP EP92400565A patent/EP0502786B1/fr not_active Expired - Lifetime
- 1992-03-04 DE DE69210076T patent/DE69210076T2/de not_active Expired - Fee Related
- 1992-03-04 DK DK92400565.5T patent/DK0502786T3/da active
- 1992-03-05 ES ES09200630A patent/ES2036145B1/es not_active Expired - Fee Related
- 1992-03-05 AU AU11429/92A patent/AU651177B2/en not_active Ceased
- 1992-03-06 US US07/847,625 patent/US5227486A/en not_active Expired - Fee Related
- 1992-03-06 RU SU925011022A patent/RU2053230C1/ru active
- 1992-03-06 CA CA002062468A patent/CA2062468A1/en not_active Abandoned
- 1992-03-06 JP JP04049964A patent/JP3084537B2/ja not_active Expired - Fee Related
- 1992-03-06 HU HU9200768A patent/HU219405B/hu not_active IP Right Cessation
- 1992-03-06 NO NO920888A patent/NO180376C/no not_active IP Right Cessation
- 1992-03-06 KR KR1019920003712A patent/KR0124133B1/ko not_active IP Right Cessation
- 1992-03-06 ZA ZA921682A patent/ZA921682B/xx unknown
-
1996
- 1996-06-27 GR GR960401710T patent/GR3020341T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0502786B1 (fr) | 1996-04-24 |
DE69210076T2 (de) | 1996-10-24 |
ES2036145A1 (es) | 1993-05-01 |
NO180376B (no) | 1996-12-30 |
JP3084537B2 (ja) | 2000-09-04 |
RU2053230C1 (ru) | 1996-01-27 |
HU9200768D0 (en) | 1992-05-28 |
YU21592A (sh) | 1994-06-24 |
ZA921682B (en) | 1992-11-25 |
NO920888D0 (no) | 1992-03-06 |
AU651177B2 (en) | 1994-07-14 |
ATE137233T1 (de) | 1996-05-15 |
HU219405B (hu) | 2001-04-28 |
FR2673628B1 (fr) | 1993-07-09 |
HUT60731A (en) | 1992-10-28 |
GR3020341T3 (en) | 1996-09-30 |
KR920018046A (ko) | 1992-10-21 |
JPH0578313A (ja) | 1993-03-30 |
KR0124133B1 (ko) | 1997-11-24 |
ES2036145B1 (es) | 1994-10-16 |
DK0502786T3 (da) | 1996-05-13 |
DE69210076D1 (de) | 1996-05-30 |
FR2673628A1 (fr) | 1992-09-11 |
EP0502786A1 (fr) | 1992-09-09 |
NO920888L (no) | 1992-09-08 |
AU1142992A (en) | 1992-09-10 |
US5227486A (en) | 1993-07-13 |
CA2062468A1 (en) | 1992-09-08 |
NO180376C (no) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU48213B (sh) | Postupak za izradu derivata aril (ili heteroaril) piperazinilbutilazola | |
NO920348L (no) | Aryl (eller heteroaryl)piperazinylalkylazolderivater, deres fremstilling og anvendelse som medikamenter | |
DK0944617T3 (da) | Krystaller af benzimidazolderivater og deres fremstilling | |
AU570067B2 (en) | Chromanylalkoxybenzyl substituted thiazolidines | |
CA2053253A1 (en) | New aryl-and heteroarylethenylene derivatives and process for their preparation | |
ATE218141T1 (de) | Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE113281T1 (de) | Pyrazol-derivate, verfahren zu deren herstellung und anwendung. | |
AU7927591A (en) | Substituted aminoalkylbiphenyl derivatives | |
CA1272482C (en) | QUINOLINECARBOXYLIC ACID DERIVATIVES | |
DK0615549T3 (da) | Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase | |
NO890440D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater. | |
AU553927B2 (en) | Oxazolo- thiazolo- imidazolo (5,4-b) pyridines | |
YU46444B (sh) | Postupak za izradu derivata imidazola | |
HU900974D0 (en) | Fungicidal compositions comprising substituted n-hydroxy-pyrazole derivatives and process for preparation of the active ingredients | |
FI971177A0 (fi) | Bisyklisiä karboksiamideja 5-HT1A-antagonisteina | |
NO852471L (no) | Fremgangsmaate for fremstilling av heterocyklylfenylformamidiner. | |
EP0268245A3 (en) | Process for the preparation of eburnamenine oxime derivatives | |
FR2794122B1 (fr) | Nouveaux antioxydants, procedes de preparation et utilisations |